BioLargo Inc
OTC:BLGO
BioLargo Inc
Research & Development
BioLargo Inc
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
BioLargo Inc
OTC:BLGO
|
Research & Development
-$2.8m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-16%
|
|
|
Sherwin-Williams Co
NYSE:SHW
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
International Flavors & Fragrances Inc
NYSE:IFF
|
Research & Development
-$694m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-11%
|
|
|
Dupont De Nemours Inc
NYSE:DD
|
Research & Development
-$193m
|
CAGR 3-Years
29%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Ecolab Inc
NYSE:ECL
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
PPG Industries Inc
NYSE:PPG
|
Research & Development
-$423m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
1%
|
|
BioLargo Inc
Glance View
BioLargo, Inc. engages in the provision of technology solutions for odor and moisture control, disinfection, and water treatment. The company is headquartered in Westminster, California and currently employs 27 full-time employees. The firm invents, develops, and commercializes platform technologies to solve environmental problems like polyfluoroalkyl substances (PFAS) contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds (VOC) control, air quality control and infection control. The company provides sustainable solutions for a range of industries and applications. The Company’s products include Advanced Oxidation System (AOS), Aqueous Electrostatic Concentrator (AEC), CupriDyne Clean industrial odor control product, Clyraguard Personal Protection Spray, and hand sanitizer. The firm provides its products through its subsidiaries, including ONM Environmental, Inc., BioLargo Water, Inc., BioLargo Water Investment Group, Inc., BioLargo Development Corp., BioLargo Engineering, Science & Technologies, LLC and Clyra Medical Technologies, Inc.
See Also
What is BioLargo Inc's Research & Development?
Research & Development
-2.8m
USD
Based on the financial report for Jun 30, 2025, BioLargo Inc's Research & Development amounts to -2.8m USD.
What is BioLargo Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-16%
Over the last year, the Research & Development growth was -11%. The average annual Research & Development growth rates for BioLargo Inc have been -25% over the past three years , -15% over the past five years , and -16% over the past ten years .
